1. Home
  2. ARR vs LMAT Comparison

ARR vs LMAT Comparison

Compare ARR & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARMOUR Residential REIT Inc.

ARR

ARMOUR Residential REIT Inc.

HOLD

Current Price

$17.10

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$91.96

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARR
LMAT
Founded
2008
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
ARR
LMAT
Price
$17.10
$91.96
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$18.50
$105.80
AVG Volume (30 Days)
2.7M
246.0K
Earning Date
04-22-2026
05-05-2026
Dividend Yield
16.69%
0.93%
EPS Growth
N/A
30.57
EPS
N/A
0.68
Revenue
N/A
$249,602,000.00
Revenue This Year
N/A
$14.21
Revenue Next Year
N/A
$8.88
P/E Ratio
$27.18
$135.79
Revenue Growth
N/A
13.53
52 Week Low
$13.98
$79.01
52 Week High
$19.31
$118.01

Technical Indicators

Market Signals
Indicator
ARR
LMAT
Relative Strength Index (RSI) 51.10 35.10
Support Level $17.04 $89.81
Resistance Level $17.24 $92.25
Average True Range (ATR) 0.26 2.86
MACD 0.02 0.21
Stochastic Oscillator 74.07 16.39

Price Performance

Historical Comparison
ARR
LMAT

About ARR ARMOUR Residential REIT Inc.

ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: